AI-based drug developer Basecamp valued at $800 million after $140 million funding round

Wait 5 sec.

The oversubscribed round was led by S32, with participation from Nvidia, Anthropic's Anthology Fund, Catalio Capital Management, the NATO Innovation Fund, the Rockefeller Foundation and Singular, among other investors.